Longati Capital
Longati Capital is a venture capital firm based in São Paulo, Brazil. This profile covers what we know about Longati Capital and how founders can get in front of it in 2026.
Longati Capital is an investment firm that offers funds, acquires and manages SMEs.
- Location
- São Paulo, Brazil
- Founded
- 2024
- Team size
- 1-10
How to pitch Longati Capital
The founders who hear back from Longati Capital lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Longati Capital
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Longati Capital." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/longati-capital
Frequently Asked Questions
What is Longati Capital?
Longati Capital is a venture capital firm based in São Paulo, Brazil. Round Funded tracks its focus, stage, and activity alongside thousands of active investors.
Where is Longati Capital based?
Longati Capital is based in São Paulo, Brazil. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Longati Capital?
Unlock a verified email for Longati Capital and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.